1-Methylbiguanide sulfate, with the CAS number 1609-00-3, is a chemical compound that belongs to the biguanide class of compounds. It is primarily recognized for its role as an antihyperglycemic agent, commonly used in the management of type 2 diabetes. The compound exhibits properties that enhance insulin sensitivity and decrease hepatic glucose production. Structurally, it features a biguanide backbone with a methyl group substitution, which contributes to its pharmacological activity. 1-Methylbiguanide sulfate is typically presented as a white to off-white crystalline powder, and it is soluble in water, making it suitable for various formulations. Its mechanism of action involves the activation of AMP-activated protein kinase (AMPK), leading to improved glucose uptake in peripheral tissues. Additionally, it may have effects on lipid metabolism and weight management. As with any pharmaceutical compound, it is essential to consider its safety profile, potential side effects, and contraindications when used in clinical settings.

1-METHYLBIGUANIDE SULPHATE

1609-00-3: 1-Methylbiguanide sulfate, with the CAS number 1609-00-3, is a chemical compound that belongs to the biguanide class of compounds. It is primarily recognized for its role as an antihyperglycemic agent, commonly used in the management of type 2 diabetes. The compound exhibits properties that enhance insulin sensitivity and decrease hepatic glucose production. Structurally, it features a biguanide backbone with a methyl group substitution, which contributes to its pharmacological activity. 1-Methylbiguanide sulfate is typically presented as a white to off-white crystalline powder, and it is soluble in water, making it suitable for various formulations. Its mechanism of action involves the activation of AMP-activated protein kinase (AMPK), leading to improved glucose uptake in peripheral tissues. Additionally, it may have effects on lipid metabolism and weight management. As with any pharmaceutical compound, it is essential to consider its safety profile, potential side effects, and contraindications when used in clinical settings.

IMIDODICARBONIMIDIC DIAMIDE, N-METHYL-

<p>1-Methyl biguanide hemisulfate monohydrate is an antidiabetic drug that belongs to the class of biguanides. It is a metformin prodrug that is hydrolyzed in vivo to produce metformin, its active form. 1-Methyl biguanide hemisulfate monohydrate has been shown to decrease blood sugar levels in diabetic patients by inhibiting gluconeogenesis and increasing the uptake of glucose into cells. 1-Methyl biguanide hemisulfate monohydrate also has two modes of action: it abolishes insulin resistance and increases cellular uptake of insulin, leading to increased activity of insulin receptors on cell membranes and increased epidermal growth factor (EGF) production.</p>

CAS 1609-00-3

1-METHYLBIGUANIDE SULPHATE

IMIDODICARBONIMIDIC DIAMIDE, N-METHYL-

Ref: IN-DA001VGO

1-Methyl biguanide hemisulfate monohydrate

Ref: 3D-FM25794